A Silicon Valley maker of surgical robots is launching a venture capital arm to invest in future leaders of minimally invasive care. Inaugural ante: $100 million.
Elevated EPA and ALA levels were associated with better outcomes for STEMI patients, including fewer cardiovascular complications and improved survival.
Tokyo-based Astellas's tracer was developed to supplement surgeries and reduces the chance of iatrogenic ureteral injury during colorectal or gynecologic procedures.
Doctors can rely on coronary artery calcium scanning to help more patients avoid a first major cardiac event, according to new research published in JAMA Cardiology.
A hearing aid manufacturer founded in the 1950s has introduced what it says is the first use of AI to optimize auditory assistance for the hearing impaired in real time.